Fisher Asset Management
COGT icon

Fisher Asset Management’s Cogent Biosciences COGT Stock Holding History

Fisher Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44M Buy
167,412
+119,498
+249% +$4.41M ﹤0.01% 441
2025
Q4 		$1.7M Sell
47,914
-55,578
-54% -$1.56M ﹤0.01% 584
2025
Q3 		$1.49M Sell
103,492
-7,416
-7% -$87.9K ﹤0.01% 629
2025
Q2 		$796K Hold
110,908
– – ﹤0.01% 721
2025
Q1 		$664K Hold
110,908
– – ﹤0.01% 747
2024
Q4 		$865K Sell
110,908
-18,507
-14% -$184K ﹤0.01% 678
2024
Q3 		$1.4M Sell
129,415
-19,630
-13% -$191K ﹤0.01% 624
2024
Q2 		$1.26M Buy
149,045
+47,514
+47% +$360K ﹤0.01% 647
2024
Q1 		$682K Sell
101,531
-260
-0.3% -$1.61K ﹤0.01% 734
2023
Q4 		$599K Buy
101,791
+33,222
+48% +$255K ﹤0.01% 751
2023
Q3 		$669K Hold
68,569
– – ﹤0.01% 808
2023
Q2 		$812K Hold
68,569
– – ﹤0.01% 815
2023
Q1 		$740K Hold
68,569
– – ﹤0.01% 804
2022
Q4 		$793K Hold
68,569
– – ﹤0.01% 798
2022
Q3 		$1.02M Buy
+68,569
New +$940K ﹤0.01% 662

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fisher Asset Management's COGT Position: Q1 2026 in Review

Fisher Asset Management increased its Cogent Biosciences (COGT) stake by 249% in Q1 2026, buying an estimated $4.41M and bringing the position to 167,412 shares worth $6.44M. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Fisher Asset Management first reported a position in COGT in Q3 2022 and has held it in 15 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Fisher Asset Management held 167,412 shares of Cogent Biosciences worth $6.44M as of Q1 2026.
  • Fisher Asset Management bought 119,498 Cogent Biosciences shares in Q1 2026, an estimated $4.41M.
  • Cogent Biosciences made up ﹤0.01% of Fisher Asset Management's portfolio in Q1 2026, its #441 holding.
  • Fisher Asset Management first reported a position in Cogent Biosciences in Q3 2022 and has held it in 15 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.